|Articles|May 8, 2020
UHPLC analysis of challenging MAbs
This application note using YMC-Triart Bio C4 shows a robust separation at high temperatures of 3 commercially available MAbs: Ofatumumab, Palivizumab, and Panitumumab.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
High-throughput Headspace Analysis of Volatile Nitrosamines and their Secondary Amine Precursors
2
GC-IMS Profiling of Flavor and Quality Changes in Cooked Crayfish
3
Detecting Estrogen Signatures in MCN Tumors via Targeted LC-MS/MS
4
Best of the Week: The Scientific Method in the Age of AI, Rewiring the Fundamentals
5
